HK1231373B - Method of manufacturing enteric soft capsule - Google Patents
Method of manufacturing enteric soft capsule Download PDFInfo
- Publication number
- HK1231373B HK1231373B HK17104964.5A HK17104964A HK1231373B HK 1231373 B HK1231373 B HK 1231373B HK 17104964 A HK17104964 A HK 17104964A HK 1231373 B HK1231373 B HK 1231373B
- Authority
- HK
- Hong Kong
- Prior art keywords
- enteric
- soft capsules
- capsule
- coated
- preparing
- Prior art date
Links
Description
技术领域Technical Field
本发明涉及一种肠溶软胶囊的制备方法,更具体地,涉及一种肠溶软胶囊的制备方法,其包括以下步骤:(a)配制含有明胶和酰胺化度为5-25%的低甲氧基果胶的肠溶胶囊外壳液,和(b)使用步骤(a)制备的肠溶胶囊外壳液通过冲切法封装胶囊内容物。The present invention relates to a method for preparing enteric-coated soft capsules, and more specifically, to a method for preparing enteric-coated soft capsules, comprising the following steps: (a) preparing an enteric-coated capsule shell liquid containing gelatin and low-methoxy pectin with an amidation degree of 5-25%, and (b) encapsulating capsule contents by punching using the enteric-coated capsule shell liquid prepared in step (a).
背景技术Background Art
传统上,包含各种活性成分的胶囊已经被广泛报道。作为这些胶囊的外壳材料,明胶和琼脂等被广泛使用。然而,以明胶和琼脂等为材料的外壳,因其在酸性环境的胃中崩解,不能用酸不稳定的物质作为活性成分。Capsules containing various active ingredients have been widely reported. Gelatin and agar are widely used as shell materials for these capsules. However, shells made of materials such as gelatin and agar disintegrate in the acidic environment of the stomach, making it difficult to use acid-labile active ingredients.
近几年,肠溶胶囊被开发起来。肠溶胶囊是其外壳对酸有耐性,因而不在胃中崩解,而在肠中崩解,释放内容物的胶囊。肠溶胶囊不仅用于以酸不稳定的物质作为活性成分含有的情形,而且用于希望通过缓释长期保持效果的物质,以及大蒜,鱼油等的在胃中消化导致的呼气时的不良气味和返味的物质的情形。In recent years, enteric-coated capsules have been developed. Enteric-coated capsules have an acid-resistant shell, so they disintegrate in the intestines rather than in the stomach, releasing their contents. Enteric-coated capsules are used not only for active ingredients containing acid-labile substances, but also for substances where sustained release is desired for long-term effects, and for substances such as garlic and fish oil that have an unpleasant odor or aftertaste in the breath after digestion in the stomach.
关于肠溶胶囊的制备方法,迄今为止已被提出的一种方法,包括以下步骤(a)制备含有成膜的水溶性聚合物和酸不溶性聚合物的溶液,将该溶液与合适的增塑剂混合以生成凝胶材料;(b)用热控制的鼓状物或表面将凝胶材料浇铸成膜或带;(c)使用旋转模技术形成软胶囊(参考专利文献1)。Regarding the preparation method of enteric-coated capsules, a method that has been proposed so far includes the following steps: (a) preparing a solution containing a film-forming water-soluble polymer and an acid-insoluble polymer, and mixing the solution with a suitable plasticizer to form a gel material; (b) casting the gel material into a film or tape using a heat-controlled drum or surface; and (c) forming a soft capsule using a rotational mold technology (reference patent document 1).
另外还公开了一种肠溶缓释软胶囊的制备方法,其特征在于,包含将明胶,作为增塑剂的多元醇,碱金属盐,水,与浓度为6-40质量%的角叉菜胶、琼脂、刺槐豆胶等多糖均匀混炼制得软胶囊原料混合物的步骤,以及使用该软胶囊原料混合物内含选自大蒜,鱼油,蜂胶,肠道细菌,以及蛋白质类药物的至少一种的步骤(参考专利文献2)。但是,2种及以上多糖是必须的,且混炼时碱金属盐是必须的,因此胶囊形成时促进了由2种多糖导致的凝胶化,出现了成形性非常差(粘合性非常差)的问题。In addition, a preparation method of an enteric-coated sustained-release soft capsule is disclosed, characterized in that the method comprises the steps of uniformly mixing gelatin, a polyol as a plasticizer, an alkali metal salt, and water with a concentration of 6-40% by mass of polysaccharides such as carrageenan, agar, and locust bean gum to prepare a soft capsule raw material mixture, and using the soft capsule raw material mixture to contain at least one of garlic, fish oil, propolis, intestinal bacteria, and a protein drug (reference patent document 2). However, two or more polysaccharides are required, and an alkali metal salt is required during mixing, so that the gelation caused by the two polysaccharides is promoted during capsule formation, resulting in a problem of very poor formability (very poor adhesion).
此外还公开了一种肠溶软胶囊的制备方法,其特征在于,具备:配制含有明胶,水,增塑剂,以及酯化度为20%-40%,相对于100重量份的明胶含量为10重量份-30重量份的低甲氧基果胶的胶囊外壳液的制备步骤,和用旋转模式成形装置向由上述胶囊外壳液形成的胶囊皮膜填充内容物形成软胶囊的成形步骤;不具备:含有使低甲氧基果胶凝胶化的多价金属离子的盐被添加至上述胶囊外壳液,同时将成形的上述软胶囊浸泡于包含上述多价金属离子的凝胶化液中的步骤(参考专利文献3)。In addition, a method for preparing enteric-coated soft capsules is disclosed, which is characterized by comprising: a preparation step of preparing a capsule shell liquid containing gelatin, water, a plasticizer, and low-methoxy pectin with an esterification degree of 20%-40% and an esterification content of 10 parts by weight to 30 parts by weight relative to 100 parts by weight of gelatin; and a forming step of filling a capsule membrane formed from the capsule shell liquid with the contents using a rotary mode forming device to form a soft capsule; and excluding the step of adding a salt containing a polyvalent metal ion that gelates the low-methoxy pectin to the capsule shell liquid and immersing the formed soft capsule in a gelling liquid containing the polyvalent metal ion (see Patent Document 3).
现有技术文献Prior art literature
专利文献Patent Literature
专利文献1:日本特表2006-505542号公报Patent Document 1: Japanese Patent Application No. 2006-505542
专利文献2:日本特开2009-185022号公报Patent Document 2: Japanese Patent Application Laid-Open No. 2009-185022
专利文献3:日本特开2010-047548号公报Patent Document 3: Japanese Patent Application Laid-Open No. 2010-047548
发明内容Summary of the Invention
发明要解决的问题Problems to be solved by the invention
本发明要解决的问题在于,提供具有肠溶性且制剂性优异的软胶囊的制备方法。The problem to be solved by the present invention is to provide a method for preparing a soft capsule having enteric solubility and excellent formulation properties.
用于解决问题的手段Means used to solve problems
本发明人等着眼于在肠溶软胶囊的制备中用于胶囊外壳的果胶的酰胺化度。在胶囊皮膜材料中使用不同酰胺化度的多种果胶,发现:通过使用酰胺化度为5-25%的低甲氧基果胶,能够制备具有肠溶性且制剂性优异的软胶囊,从而完成了本发明。The present inventors focused on the degree of amidation of pectin used in the capsule shell of enteric soft capsules. Using various pectins with varying degrees of amidation as the capsule membrane material, they discovered that using low-methoxyl pectin with a degree of amidation of 5-25% allowed the preparation of soft capsules with enteric solubility and excellent formulation properties, leading to the present invention.
即,本发明涉及以下的(1)-(6)。That is, the present invention relates to the following (1) to (6).
(1)一种肠溶软胶囊的制备方法,其特征在于,包括以下步骤(a)配制含有明胶和酰胺化度为5-25%的低甲氧基果胶的肠溶胶囊外壳液,和(b)使用步骤(a)制备的肠溶胶囊外壳液通过冲切法来封装胶囊内容物。(1) A method for preparing enteric soft capsules, characterized in that it comprises the following steps: (a) preparing an enteric capsule shell liquid containing gelatin and low-methoxy pectin with an amidation degree of 5-25%, and (b) using the enteric capsule shell liquid prepared in step (a) to encapsulate capsule contents by a punching method.
(2)如上述(1)所述肠溶软胶囊的制备方法,其特征在于,明胶的凝冻强度为160-300Bloom。(2) The method for preparing the enteric-coated soft capsules as described in (1) above is characterized in that the gel strength of the gelatin is 160-300 Bloom.
(3)如上述(1)或(2)所述肠溶软胶囊的制备方法,其特征在于,低甲氧基果胶的酯化度为20-40%。(3) The method for preparing the enteric-coated soft capsules as described in (1) or (2) above, characterized in that the degree of esterification of the low-methoxyl pectin is 20-40%.
(4)如上述(1)-(3)的任一项所述肠溶软胶囊的制备方法,其特征在于,相对于100质量份的明胶,肠溶胶囊外壳液含有30-35质量份的低甲氧基果胶。(4) The method for preparing the enteric-coated soft capsule according to any one of (1) to (3) above, wherein the enteric-coated capsule shell liquid contains 30-35 parts by mass of low-methoxyl pectin relative to 100 parts by mass of gelatin.
(5)如上述(1)-(4)的任一项所述肠溶软胶囊的制备方法,其特征在于,将低甲氧基果胶在甘油中分散后溶解于温水中,然后加入明胶进行溶解,把混合物过滤后减压消泡(脱泡)。(5) A method for preparing enteric-coated soft capsules as described in any one of (1) to (4) above, characterized in that low-methoxyl pectin is dispersed in glycerol and then dissolved in warm water, gelatin is then added and dissolved, and the mixture is filtered and defoamed under reduced pressure (degassing).
(6)如上述(1)-(5)的任一项所述肠溶软胶囊的制备方法,其特征在于,所述封装使肠溶胶囊外壳的厚度为0.3-1.2mm。(6) The method for preparing the enteric-coated soft capsule according to any one of (1) to (5) above, wherein the encapsulation is performed so that the thickness of the shell of the enteric-coated capsule is 0.3-1.2 mm.
发明效果Effects of the Invention
由本发明的肠溶软胶囊的制备方法制备的肠溶软胶囊具有肠溶性且制剂性优异,因此能够长期保存,且能够使内容物含有酸不稳定的物质,此外即使内容物含有大蒜,鱼油等的在胃中消化导致的呼气的不良气味和返味的物质,也能够防止服用后的呼气的不良气味和返味。The enteric-coated soft capsules prepared by the method for preparing enteric-coated soft capsules of the present invention have enteric solubility and excellent preparation properties, and therefore can be stored for a long time. The contents can contain acid-unstable substances. Furthermore, even if the contents contain substances such as garlic and fish oil that cause bad odor and aftertaste in breath caused by digestion in the stomach, the bad odor and aftertaste in breath after administration can be prevented.
具体实施方式DETAILED DESCRIPTION
本发明的肠溶软胶囊的制备方法,没有特别的限制,为包括以下步骤的肠溶软胶囊的制备方法:(a)配制含有明胶和酰胺化度为5-25%的低甲氧基果胶的肠溶胶囊外壳液,和(b)使用步骤(a)制备的肠溶胶囊外壳液通过冲切法来封装胶囊内容物。肠溶性是指不在胃中溶解而在肠中溶解的性质。The method for preparing the enteric-coated soft capsules of the present invention is not particularly limited and comprises the following steps: (a) preparing an enteric-coated capsule shell solution containing gelatin and low-methoxyl pectin having an amidation degree of 5-25%, and (b) using the enteric-coated capsule shell solution prepared in step (a) to encapsulate the capsule contents by punching. Enteric solubility refers to the property of dissolving in the intestines rather than in the stomach.
本发明中的明胶,没有特别的限制,包括凝冻强度为160-300Bloom,优选200-300Bloom的明胶。此外,可以混合使用凝冻强度2种及以上不同的明胶,譬如可将凝冻强度为200Bloom和300Bloom的2种明胶混合来调整凝冻强度。The gelatin used in the present invention is not particularly limited and includes gelatin with a gel strength of 160-300 Bloom, preferably 200-300 Bloom. In addition, two or more gelatins with different gel strengths can be mixed and used. For example, gelatin with a gel strength of 200 Bloom and gelatin with a gel strength of 300 Bloom can be mixed to adjust the gel strength.
本发明中,低甲氧基果胶(LM果胶)是指酯化度(DE)小于50%的果胶,该酯化度优选为20-40%,更优选为22-38%,进一步优选为22-32%。酯化度是指半乳糖醛酸总量中被甲酯化物质的比例,其值可以通过被甲酯化的半乳糖醛酸量÷半乳糖醛酸总量×100%计算得出。In the present invention, low methoxyl pectin (LM pectin) refers to pectin with a degree of esterification (DE) of less than 50%. The degree of esterification is preferably 20-40%, more preferably 22-38%, and even more preferably 22-32%. The degree of esterification refers to the proportion of methyl-esterified galacturonic acid in the total amount of galacturonic acid, and can be calculated by dividing the amount of methyl-esterified galacturonic acid by the total amount of galacturonic acid × 100%.
本发明中,酰胺化度(DA)是指半乳糖醛酸总量中被酰胺化物质的比例,可以通过被酰胺化的半乳糖醛酸量÷半乳糖醛酸总量×100%计算得出。上述低甲氧基果胶的酰胺化度的例子为5-25%,优选为6-23%,更优选12-23%。In the present invention, the degree of amidation (DA) refers to the proportion of amidated species in the total amount of galacturonic acid, which can be calculated by: the amount of amidated galacturonic acid / the total amount of galacturonic acid × 100%. The degree of amidation of the low-methoxyl pectin is, for example, 5-25%, preferably 6-23%, and more preferably 12-23%.
本发明的肠溶胶囊外壳液的配制方法,没有特别的限制,包括以下方法:所述方法包括可将酰胺化度为5-25%的低甲氧基果胶溶解于水中,然后加入明胶进行溶解。从确保外壳液的均一性,防止胶囊外壳的脆弱化,防止胶囊的变形、粘结不良等品质确保的方面考虑,优选将上述低甲氧基果胶分散于例如甘油的增塑剂后溶解于温水中,以及用筛孔为0.5mm以下,优选为0.3mm以下的目筛过滤制备的肠溶胶囊外壳液,除去不溶物(例如不溶的粉块)或杂质,然后在外壳液熔融状态下进一步真空减压消泡。The method for preparing the shell liquid for enteric-coated capsules of the present invention is not particularly limited and includes the following method: the method comprises dissolving low-methoxyl pectin having an amidation degree of 5-25% in water, and then adding gelatin to dissolve the mixture. To ensure the uniformity of the shell liquid, prevent brittleness of the capsule shell, and prevent deformation and poor adhesion of the capsule, the low-methoxyl pectin is preferably dispersed in a plasticizer such as glycerin, then dissolved in warm water, and the prepared shell liquid is filtered through a sieve with a mesh size of 0.5 mm or less, preferably 0.3 mm or less, to remove insoluble matter (e.g., insoluble powder lumps) or impurities. The shell liquid is then further subjected to vacuum decompression and defoaming while in its molten state.
本发明中,通过冲切法来封装胶囊内容物的方法是将胶囊外壳液延展而成的2片明胶片送至一对形成用模具,在该2片薄片之间注入内容液,通过冲切填充内容物使胶囊成形的方法,没有特别的限制,可以为采用圆筒状模具的旋转模法、平板状模具的平板法等封装胶囊内容物的方法。上述模具的材质没有特别的限制,优选金属制的金属模具。上述旋转模法、平板法可以采用市售的旋转模式软胶囊制备装置、平板式软胶囊制备装置进行。此外,采用冲切法时,成形时因压接产生接缝,该接缝的粘合性(密封性、粘附性)低时胶囊容易崩解。但是,由本发明制备的肠溶软胶囊因其外壳有酰胺化度为5-25%的低甲氧基果胶,接缝的粘合性高,能够长期稳定保存。In the present invention, the method for encapsulating the capsule contents by punching is to feed two gelatin sheets formed by stretching the capsule shell liquid to a pair of forming molds, inject the liquid between the two sheets, and then punch out the contents to form the capsule. The method is not particularly limited and can be a rotary mold method using a cylindrical mold, a flat plate method using a flat plate mold, or other methods for encapsulating the capsule contents. The material of the mold is not particularly limited, and metal molds are preferably metal molds. The rotary mold method and the flat plate method can be carried out using commercially available rotary mode soft capsule production equipment or flat plate soft capsule production equipment. In addition, when using the punching method, a seam is formed due to compression during forming. If the adhesiveness (sealing, adhesion) of the seam is low, the capsule is easily disintegrated. However, the enteric-coated soft capsules prepared by the present invention have a high adhesiveness of the seam because their shells contain low-methoxyl pectin with a degree of amidation of 5-25%, allowing for long-term stable storage.
本发明中,胶囊内容物没有特别限制,可以是固体也可以是液体,例如医药成分,营养补充剂成分,健康食品成分等。具体的例子包括在胃中消化时导致呼气时有不良气味和返味的物质,例如鱼油、大蒜、维生素B1、所称的蛋油(卵油)(传统的健康食品原料,边搅拌蛋黄边用铁锅等长时间小火加热得到的褐色到黑色液体),酸不稳定的肠道细菌,例如粪链球菌(スプレプトコックス·フェシウム)、乳酸乳球菌(ラクトコックス·ラクチス亜種·ラクチス)、瑞士乳杆菌(ラクトバチルス·ヘルペティクス)、嗜酸乳杆菌(ラクトバチルス·アシドフィルス)、干酪乳杆菌(ラクトバチルス·カゼイ)等乳酸菌、长双歧杆菌(ビフィドバクテリウム·ロンガム)、两歧双歧杆菌(ビフィドバクテリウム·ビフィダム)等双歧杆菌,辣椒原料、辣椒素等刺激胃的成分,富马酸亚铁、干燥硫酸亚铁等铁剂,散热剂,镇痛剂,消炎剂,抗肿瘤剂,抗菌剂等用于通过缓释使效果长期保持的制剂。In the present invention, the contents of the capsule are not particularly limited and may be solid or liquid, such as pharmaceutical ingredients, nutritional supplement ingredients, health food ingredients, etc. Specific examples include substances that cause an unpleasant odor or aftertaste in the breath during digestion in the stomach, such as fish oil, garlic, vitamin B1, so-called egg oil (a traditional health food ingredient, a brown to black liquid obtained by heating egg yolks in an iron pan or other similar medium over a low heat for a long time while stirring), acid-labile intestinal bacteria, such as Streptococcus faecalis, Lactococcus lactis, and Lactobacillus helveticus. Lactic acid bacteria such as Lactobacillus acidophilus (ラクトバチルス·アシドフィダム), Lactobacillus casei (ラクトバチルス·カゼイ), Bifidobacterium such as Bifidobacterium longum (ビフィドバクテリウム·ロンガム), Bifidobacterium bifidum (ビフィドバクテリウム·ビフィダム), ingredients that irritate the stomach such as chili pepper raw materials and capsaicin, iron supplements such as ferrous fumarate and dried ferrous sulfate, heat dissipating agents, analgesics, anti-inflammatory agents, antitumor agents, antibacterial agents, etc. are used in preparations that maintain the effect for a long time through sustained release.
上述胶囊内容物中,除上述成分外,还可以含有所需的硬化油、中链脂肪酸甘油三酯(MCT)、EPA、DHA、鲨鱼肝油、鳕鱼肝油等油脂,卵磷脂、聚甘油脂肪酸酯、醇类等调整表面活性的添加剂,缓冲液,水,明胶或卡拉胶等的凝胶化剂,pH调节剂,气相二氧化硅等多孔质微粒子粉末,甜味料等呈味剂,香料,溶解助剂,粘度调节剂,维生素E、BHT、BHA所代表的抗氧化剂等。The contents of the capsules may contain, in addition to the above ingredients, necessary hardened oils, medium-chain triglycerides (MCT), EPA, DHA, shark liver oil, cod liver oil and other fats and oils, lecithin, polyglycerol fatty acid esters, alcohols and other additives for adjusting surface activity, buffers, water, gelling agents such as gelatin or carrageenan, pH adjusters, porous fine particle powders such as fumed silica, flavoring agents such as sweeteners, flavorings, solubility aids, viscosity modifiers, antioxidants such as vitamin E, BHT, and BHA, and the like.
本发明的肠溶胶囊外壳液中,低甲氧基果胶相对于明胶的含量并没有特别的限制,但相对于100质量份的明胶,低甲氧基果胶的含量优选为20-40质量份,更优选为30-35质量份,进一步优选为31-33质量份。In the shell liquid of the enteric capsule of the present invention, the content of low methoxy pectin relative to gelatin is not particularly limited, but the content of low methoxy pectin is preferably 20-40 parts by mass, more preferably 30-35 parts by mass, and even more preferably 31-33 parts by mass relative to 100 parts by mass of gelatin.
本发明中,封装胶囊内容物时,外壳的膜厚优选0.3-1.2mm,更优选0.4-1.0mm。In the present invention, when encapsulating the contents of the capsule, the thickness of the outer shell is preferably 0.3-1.2 mm, more preferably 0.4-1.0 mm.
本发明的肠溶胶囊外壳液中,根据需要可以含有甘油等增塑剂,磷酸钠等pH调节剂,柠檬酸三钠、偏磷酸钠等螯合剂,乳酸钙、氯化钾等凝胶促进剂,聚甘油脂肪酸酯、卵磷脂等表面活性剂,甜味料,香料,防腐剂,着色剂等。基于胶囊的成形性和粘合性的考虑,优选不混合凝胶促进剂于外壳液。凝胶促进剂,可在胶囊成形后,在任意的时间(干燥前,干燥中或干燥后)通过浸泡处理或喷涂等方法使其含有。The shell liquid of the enteric-coated capsules of the present invention may contain, as needed, plasticizers such as glycerol, pH regulators such as sodium phosphate, chelating agents such as trisodium citrate and sodium metaphosphate, gelling agents such as calcium lactate and potassium chloride, surfactants such as polyglycerol fatty acid esters and lecithin, sweeteners, flavorings, preservatives, colorants, and the like. Based on considerations of capsule formability and adhesion, it is preferred not to mix gelling agents with the shell liquid. The gelling agent may be added to the capsule at any time after formation (before, during, or after drying) by immersion treatment or spraying.
具体实施方式DETAILED DESCRIPTION
实施例1Example 1
[崩解实验][Disintegration test]
(软胶囊的制备)(Preparation of Soft Capsules)
将24质量份的果胶(DE30、DA17)分散于30质量份的甘油,溶解于温水(80℃)中,进一步添加60质量份的明胶(300Bloom)和16质量份的明胶(200Bloom)于70℃溶解,用100目的目筛(筛孔为0.15mm)过滤后进行减压消泡,制备本发明的胶囊外壳液。再者,将30质量份的甘油溶解于80℃的温水中,进一步添加100质量份的明胶(200Bloom)于70℃溶解,用100目的目筛(筛孔为0.15mm)过滤后减压消泡,来制备对照包衣液。各胶囊外壳液在60℃都有流动性,都可以使用旋转装置。The capsule shell solution of the present invention was prepared by dispersing 24 parts by mass of pectin (DE30, DA17) in 30 parts by mass of glycerin and dissolving the solution in warm water (80°C). 60 parts by mass of gelatin (300 Bloom) and 16 parts by mass of gelatin (200 Bloom) were added and dissolved at 70°C. The solution was filtered through a 100-mesh sieve (0.15 mm opening) and then defoamed under reduced pressure. Furthermore, a control coating solution was prepared by dissolving 30 parts by mass of glycerin in warm water at 80°C, adding 100 parts by mass of gelatin (200 Bloom), dissolving the solution at 70°C, filtering through a 100-mesh sieve (0.15 mm opening), and then defoaming under reduced pressure. Each capsule shell solution had fluidity at 60°C and could be used in a rotary device.
然后,采用旋转模式软胶囊制备装置(富士胶囊公司制),将250mg胶囊内容物(含DHA、EPA的鱼油)封装于由上述本发明胶囊外壳液或对照外壳液延展而成的约0.8mm厚的皮膜片中。然后,在30℃、湿度35%的除湿环境下旋转干燥12小时制备Oval-5型软胶囊。制得的胶囊干燥后的皮膜厚度为0.5mm,粘合率(最薄部的接合面厚度÷平均膜厚;视觉测量)为85%,非常良好。Next, using a rotary soft capsule preparation apparatus (manufactured by Fuji Capsule Co., Ltd.), 250 mg of the capsule contents (fish oil containing DHA and EPA) were encapsulated in a membrane sheet approximately 0.8 mm thick, formed from the aforementioned capsule shell solution of the present invention or the control shell solution. Subsequently, the Oval-5 soft capsules were rotary dried for 12 hours in a dehumidified environment at 30°C and 35% humidity to produce the Oval-5 soft capsules. The resulting capsules had a membrane thickness of 0.5 mm after drying, and a very good adhesion ratio (thickness of the thinnest joint surface divided by average membrane thickness; visually measured) of 85%.
(结果)(result)
服用使用本发明的胶囊外壳液制得的软胶囊以及使用对照外壳液制得的软胶囊,60分钟后确认呼气的气味。结果,服用使用本发明的胶囊外壳液制得的软胶囊时,没有感觉到鱼产生的腥味,而服用使用对照外壳液制得的软胶囊时,感觉到了鱼产生的腥味。Soft capsules made with the capsule shell solution of the present invention and soft capsules made with a control shell solution were taken, and the odor of exhaled breath was examined 60 minutes later. The soft capsules made with the capsule shell solution of the present invention did not produce a fishy odor, while the soft capsules made with the control shell solution did produce a fishy odor.
实施例2Example 2
制剂性和肠溶性试验1Formulation and enteric dissolution test 1
(软胶囊的制备)(Preparation of Soft Capsules)
分别将以下表1所示的31.5质量份的果胶分散于40质量份的甘油,溶解于温水(80℃)中,进一步添加79质量份的明胶(300Bloom)、21质量份的明胶(200Bloom)于70℃溶解,用60目的目筛(筛孔为0.25mm)过滤后进行减压消泡,制备胶囊外壳液。表中,DE表示各果胶的酯化度(%),DA表示各果胶的酰胺化度(%)。31.5 parts by mass of pectin shown in Table 1 below was dispersed in 40 parts by mass of glycerin and dissolved in warm water (80°C). 79 parts by mass of gelatin (300 Bloom) and 21 parts by mass of gelatin (200 Bloom) were further added and dissolved at 70°C. The mixture was filtered through a 60-mesh sieve (0.25 mm opening) and then defoamed under reduced pressure to prepare a capsule shell liquid. In the table, DE represents the degree of esterification (%) of each pectin, and DA represents the degree of amidation (%) of each pectin.
表1Table 1
然后,使用平板式软胶囊制备装置(富士胶囊公司制),将中链脂肪酸甘油三酯(MCT:coconard MT:花王公司制)作为胶囊内容物以每粒平均0.45mL的量封装于由上述胶囊外壳液延展而成的厚度为约0.8mm的外壳片中。然后,在25℃、不调整湿度的环境下静置干燥18小时制备Oval-5型软胶囊。将使用含有果胶-1到果胶-4的外壳液制备的各软胶囊作为实施例制品1-4,使用果胶-5制备的软胶囊作为比较品。制得的软胶囊干燥后的外壳厚度为0.5mm,粘合率(最薄部的接合面厚度÷平均外壳厚度;视觉测量)为60%,作为由平板法制得的胶囊这是良好的。Then, using a flat-plate soft capsule preparation device (manufactured by Fuji Capsule Co., Ltd.), medium-chain fatty acid triglycerides (MCT: coconard MT: manufactured by Kao Corporation) were encapsulated as capsule contents in an average amount of 0.45 mL per capsule in a shell sheet with a thickness of about 0.8 mm formed by extending the above-mentioned capsule shell liquid. Then, the Oval-5 type soft capsules were prepared by standing and drying for 18 hours at 25°C without adjusting the humidity. The soft capsules prepared using shell liquids containing pectin-1 to pectin-4 were used as example products 1-4, and the soft capsules prepared using pectin-5 were used as comparative products. The shell thickness of the prepared soft capsules after drying was 0.5 mm, and the bonding rate (thickness of the joint surface of the thinnest part ÷ average shell thickness; visual measurement) was 60%, which is good for capsules prepared by the flat plate method.
对制得的软胶囊进行制剂性评价和肠溶性评价。关于制剂性评价,考察其外壳液的流动性(向装置中注入时有无障碍),◎表示完全没有障碍,○表示基本没有障碍,△表示略有障碍,×表示有障碍无法进行。进而,考察胶囊形成时的粘合性(片材之间的接合面的粘附状态),◎表示非常良好,○表示良好,△表示稍稍不良,×表示不良。The resulting soft capsules were evaluated for formulation properties and enteric solubility. The formulation properties were evaluated for the fluidity of the shell liquid (whether there were any obstacles when injecting it into the device), with ◎ indicating no obstacles at all, ○ indicating almost no obstacles, △ indicating slight obstacles, and × indicating obstacles preventing injection. Furthermore, the adhesiveness of the capsules during formation (the adhesion between the sheets) was evaluated, with ◎ indicating very good, ○ indicating good, △ indicating slightly poor, and × indicating poor.
关于肠溶性评价,根据如下所示的崩解试验,采用第1液(37℃)的崩解试验的120分钟后的观察结果中,○表示没有崩解,×表示有崩解;采用第2液的崩解试验的30分钟后的观察结果中,○表示完全崩解,×表示未完全崩解。Enteric solubility was evaluated by the disintegration test shown below. In the disintegration test using the first solution (37°C), observation results after 120 minutes were as follows: ○ indicates no disintegration, and × indicates disintegration. In the disintegration test using the second solution, observation results after 30 minutes were as follows: ○ indicates complete disintegration, and × indicates incomplete disintegration.
制备得到的软胶囊的崩解试验是根据文献(第16版日本药典解说(日本薬局方解説書)东京广川书店出版B589(2011))所记载的方法修改后进行的。崩解试验器采用NT-40H(富士产业公司制)。分别用关东化学公司制试剂“崩解试验第1液/溶出度试验第1液(崩壊試験第1液/溶出試験第1液)”(pH1.2)、关东化学公司制试剂“崩解试验第2液(崩壊試験第2液)”(pH6.8)对18个胶囊进行不使用辅助板(实施例制品1-4)和使用辅助板(仅实施例制品2)的试验。胶囊破裂或者其外壳开口、破损视为崩解。The disintegration test of the prepared soft capsule was carried out after modification according to the method described in the literature (Explanation of the Japanese Pharmacopoeia, 16th edition (Explanation of the Japanese Pharmacopoeia), published by Tokyo Hirokawa Shoten B589 (2011)). The disintegration tester used was NT-40H (manufactured by Fuji Sangyo Co., Ltd.). 18 capsules were tested without using an auxiliary plate (Example products 1-4) and with using an auxiliary plate (Example product 2 only) using the reagent "Disintegration test 1st liquid/Dissolution test 1st liquid (Disintegration test 1st liquid/Dissolution test 1st liquid)" (pH 1.2) manufactured by Kanto Chemical Co., Ltd. and the reagent "Disintegration test 2nd liquid (Disintegration test 2nd liquid)" (pH 6.8) manufactured by Kanto Chemical Co., Ltd. The capsule was ruptured or its shell was opened or damaged. It was regarded as disintegration.
(结果)(result)
制剂性和肠溶性的调查结果如表2所示。如表2所示,制剂性方面,实施品1-4均良好。此外,肠溶性方面,实施例制品1-4(无辅助板的情形),根据采用第1液的崩解试验,120分钟后18个软胶囊均未见崩解,根据使用新胶囊的崩解试验第2液的试验,5分钟后出现崩解,30分钟后18个软胶囊全部崩解。关于实施品2(有辅助板的情形),根据采用第1液的崩解试验,120分钟后18个软胶囊均未见崩解,根据使用新胶囊的崩解试验第2液的试验,3分钟后出现开口,30分钟后18个软胶囊全部崩解。The results of investigation of preparation property and enteric solubility are as shown in Table 2.As shown in Table 2, preparation property aspect, implementation product 1-4 is all good.In addition, enteric solubility aspect, embodiment product 1-4 (the situation without auxiliary plate), according to the disintegration test that adopts the 1st liquid, after 120 minutes, 18 soft capsules all had no disintegration, according to the test of the disintegration test the 2nd liquid using new capsule, disintegration occurred after 5 minutes, and after 30 minutes, 18 soft capsules all disintegrated.About implementation product 2 (the situation with auxiliary plate), according to the disintegration test that adopts the 1st liquid, after 120 minutes, 18 soft capsules all had no disintegration, according to the test of the disintegration test the 2nd liquid using new capsule, opening occurred after 3 minutes, and after 30 minutes, 18 soft capsules all disintegrated.
因此,可以看出使用含有明胶和酰胺化度为5-25%的低甲氧基果胶的肠溶胶囊外壳液通过冲切来制备软胶囊,可以制得制剂性和肠溶性优异的软胶囊。Therefore, it can be seen that soft capsules with excellent preparation properties and enteric solubility can be prepared by punching out an enteric capsule shell liquid containing gelatin and low methoxy pectin with an amidation degree of 5-25%.
表2Table 2
实施例3Example 3
制剂性和肠溶性试验2Formulation and enteric dissolution test 2
(软胶囊的制备)(Preparation of Soft Capsules)
分别将上述表1所示的20质量部的果胶-1、果胶-2、果胶-4分散于40质量份的甘油,溶解于温水(80℃)中,进一步添加79质量份的明胶(300Bloom)、21质量份的明胶(200Bloom)于70℃溶解,用60目的目筛(筛孔为0.25mm)过滤后进行减压消泡,制备胶囊外壳液。20 parts by weight of each of pectin-1, pectin-2, and pectin-4 shown in Table 1 were dispersed in 40 parts by weight of glycerin and dissolved in warm water (80°C). 79 parts by weight of gelatin (300 Bloom) and 21 parts by weight of gelatin (200 Bloom) were further added and dissolved at 70°C. The mixture was filtered through a 60-mesh sieve (0.25 mm opening) and defoamed under reduced pressure to prepare a capsule shell liquid.
然后,使用平板式软胶囊制备装置(富士胶囊公司制),采用与上述相同的方法,将MCT作为内容物制备Oval-5型软胶囊。将用果胶-1、果胶-2、果胶-4分别制得的软胶囊作为实施例制品5-7。Then, using a flat-plate soft capsule preparation apparatus (manufactured by Fuji Capsule Co., Ltd.), Oval-5 type soft capsules were prepared using MCT as the content using the same method as described above. Soft capsules prepared using pectin-1, pectin-2, and pectin-4, respectively, were designated as Examples 5-7.
关于制得的软胶囊,采用与上述相同方法进行制剂性评价和肠溶性评价。结果如表3所示。The obtained soft capsules were evaluated for formulation properties and enteric solubility using the same methods as above. The results are shown in Table 3.
表3Table 3
(结果)(result)
实施例制品5-7中,关于制剂性中的外壳流动性,与实施品1、2、4相比略差,但基本没有障碍;关于粘合性,与实施例制品1-4相比略差;而关于肠溶性,与实施例制品1-4一样良好。In Example products 5-7, the shell fluidity in the formulation properties was slightly inferior to that of Example products 1, 2, and 4, but there was basically no problem; the adhesiveness was slightly inferior to that of Example products 1-4; and the enteric solubility was as good as that of Example products 1-4.
产业利用性Industrial applicability
本发明的肠溶软胶囊具有优异的肠溶性和制剂性,可用于药品,营养补充剂,健康食品领域。The enteric-coated soft capsule of the present invention has excellent enteric solubility and preparation properties, and can be used in the fields of medicines, nutritional supplements, and health foods.
Claims (17)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014205991 | 2014-10-06 | ||
| JP2014-205991 | 2014-10-06 | ||
| PCT/JP2015/005083 WO2016056230A1 (en) | 2014-10-06 | 2015-10-06 | Method of producing enteric soft capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK1231373A1 HK1231373A1 (en) | 2017-12-22 |
| HK1231373B true HK1231373B (en) | 2020-07-17 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106456558B (en) | The preparation method of enteric soft capsules | |
| CN106714786B (en) | Manufacturing method of enteric-coated seamless soft capsule | |
| CN103327990A (en) | Capsule for delivering bifidobacterium into large intestine and method for producing same | |
| CN107921142B (en) | Enteric-coated capsules | |
| JP6292938B2 (en) | Soft capsule film and soft capsule | |
| HK1231373B (en) | Method of manufacturing enteric soft capsule | |
| JP2005139152A (en) | Capsule coating film composition and gelatin capsule | |
| HK1232463B (en) | Method of manufacturing enteric seamless soft capsule | |
| HK1232463A1 (en) | Method of manufacturing enteric seamless soft capsule | |
| NZ730337B2 (en) | Method of manufacturing enteric seamless soft capsule | |
| CN118284404A (en) | Compositions, gelatin films and capsules containing gelatin |